Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
International Journal of Cancer
|
September 3, 2022
The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancers
Lena Schreiberhuber, Chiara Herzog, Charlotte D Vavourakis, et al.
Clinical Epigenetics
|
September 17, 2024
Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarrays
Tatiana Nazarenko, Charlotte Dafni Vavourakis, Allison Jones, et al.
The Lancet. Oncology
|
July 14, 2019
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study
Nuno R Nené, Daniel Reisel, Andreas Leimbach, et al.
Clinical Epigenetics
|
November 22, 2022
DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
Chiara Herzog, Karin Sundström, Allison Jones, et al.
Plos One
|
December 3, 2015
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers
Thomas E Bartlett, Allison Jones, Ellen L Goode, et al.
Genome Medicine
|
December 23, 2017
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
Martin Widschwendter, Michal Zikan, Benjamin Wahl, et al.
Oncogene
|
May 6, 2003
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells
Alan Mackay, Chris Jones, Tim Dexter, et al.
Genome Biology
|
February 22, 2022
Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock
James E Barrett, Chiara Herzog, Yoo-Na Kim, et al.
Genome Biology
|
June 29, 2022
Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock
J James E Barrett, Chiara Herzog, Yoo-Na Kim, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer
Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
International Journal of Cancer
|
September 3, 2022
The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancers
Lena Schreiberhuber, Chiara Herzog, Charlotte D Vavourakis, et al.
Clinical Epigenetics
|
September 17, 2024
Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarrays
Tatiana Nazarenko, Charlotte Dafni Vavourakis, Allison Jones, et al.
The Lancet. Oncology
|
July 14, 2019
Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study
Nuno R Nené, Daniel Reisel, Andreas Leimbach, et al.
Clinical Epigenetics
|
November 22, 2022
DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
Chiara Herzog, Karin Sundström, Allison Jones, et al.
Plos One
|
December 3, 2015
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers
Thomas E Bartlett, Allison Jones, Ellen L Goode, et al.
Genome Medicine
|
December 23, 2017
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
Martin Widschwendter, Michal Zikan, Benjamin Wahl, et al.
Oncogene
|
May 6, 2003
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells
Alan Mackay, Chris Jones, Tim Dexter, et al.
Genome Biology
|
February 22, 2022
Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock
James E Barrett, Chiara Herzog, Yoo-Na Kim, et al.
Genome Biology
|
June 29, 2022
Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock
J James E Barrett, Chiara Herzog, Yoo-Na Kim, et al.
Page
of 9